BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12453547)

  • 1. Effect of nebivolol on left ventricular function in patients with chronic heart failure: a pilot study.
    Brehm BR; Wolf SC; Görner S; Buck-Müller N; Risler T
    Eur J Heart Fail; 2002 Dec; 4(6):757-63. PubMed ID: 12453547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC; Buck-Müller N; Görner S; Risler T; Brehm BR
    Med Klin (Munich); 2003 Jan; 98(1):1-6. PubMed ID: 12540987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Nebivolol on left ventricular function and exercise capacity in patients with non-ischaemic dilated cardiomyopathy. A randomised placebo-controlled study.
    Patrianakos AP; Parthenakis FI; Mavrakis HE; Saatsaki M; Diakakis GF; Chlouverakis GI; Vardas PE
    Hellenic J Cardiol; 2005; 46(3):199-207. PubMed ID: 15981555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction.
    Rousseau MF; Chapelle F; Van Eyll C; Stoleru L; Hager D; Van Nueten L; Pouleur H
    J Card Fail; 1996 Mar; 2(1):15-23. PubMed ID: 8798100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: the CARNEBI trial.
    Contini M; Apostolo A; Cattadori G; Paolillo S; Iorio A; Bertella E; Salvioni E; Alimento M; Farina S; Palermo P; Loguercio M; Mantegazza V; Karsten M; Sciomer S; Magrì D; Fiorentini C; Agostoni P
    Int J Cardiol; 2013 Oct; 168(3):2134-40. PubMed ID: 23506636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the long-term administration of nebivolol on clinical symptoms, exercise capacity and left ventricular function in patients with heart failure and preserved left ventricular ejection fraction: background, aims and design of the ELANDD study.
    Kamp O; Metra M; De Keulenaer GW; Pieske B; Conraads V; Zamorano J; Huysse L; Vardas PE; Böhm M; Dei Cas L
    Clin Res Cardiol; 2010 Feb; 99(2):75-82. PubMed ID: 20039172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
    Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
    Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study.
    Conraads VM; Metra M; Kamp O; De Keulenaer GW; Pieske B; Zamorano J; Vardas PE; Böhm M; Dei Cas L
    Eur J Heart Fail; 2012 Feb; 14(2):219-25. PubMed ID: 22147202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy.
    Wisenbaugh T; Katz I; Davis J; Essop R; Skoularigis J; Middlemost S; Röthlisberger C; Skudicky D; Sareli P
    J Am Coll Cardiol; 1993 Apr; 21(5):1094-100. PubMed ID: 8096228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optimization of use of beta-adrenoblockers in the treatment of chronic heart failure in the outpatient setting].
    Zhubrina ES; Ovchinnikov AG; Seredenina EM; Patrusheva IF; Blankova ZN; Kuz'mina AE; Kheĭmets GI; Ageev FT
    Ter Arkh; 2009; 81(11):35-40. PubMed ID: 20141011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-immunological disorders in patients with ischemic heart disease combined with metabolic syndrome and modulating effect of nebivolol for their correction].
    Tepliakov AT; Bolotskaia LA; Vdovina TV; Stepacheva TA; Kuznetsova AV
    Ter Arkh; 2008; 80(12):44-52. PubMed ID: 19227907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemodynamic effects of moderate doses of nebivolol versus metoprolol in patients with systolic heart failure.
    Triposkiadis F; Giamouzis G; Kelepeshis G; Sitafidis G; Skoularigis J; Demopoulos V
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):71-7. PubMed ID: 17323786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study.
    Edes I; Gasior Z; Wita K
    Eur J Heart Fail; 2005 Jun; 7(4):631-9. PubMed ID: 15921805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy.
    Ghio S; Magrini G; Serio A; Klersy C; Fucili A; Ronaszèki A; Karpati P; Mordenti G; Capriati A; Poole-Wilson PA; Tavazzi L;
    Eur Heart J; 2006 Mar; 27(5):562-8. PubMed ID: 16443607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial.
    Dobre D; van Veldhuisen DJ; Mordenti G; Vintila M; Haaijer-Ruskamp FM; Coats AJ; Poole-Wilson PA; Flather MD;
    Am Heart J; 2007 Jul; 154(1):109-15. PubMed ID: 17584562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
    Flather MD; Shibata MC; Coats AJ; Van Veldhuisen DJ; Parkhomenko A; Borbola J; Cohen-Solal A; Dumitrascu D; Ferrari R; Lechat P; Soler-Soler J; Tavazzi L; Spinarova L; Toman J; Böhm M; Anker SD; Thompson SG; Poole-Wilson PA;
    Eur Heart J; 2005 Feb; 26(3):215-25. PubMed ID: 15642700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiischemic and metabolic effects of nebivolol and metaprolol CR/XL (betalok ZOK) in patients with postinfarction heart dysfunction].
    Tepliakov AT; Kuznetsova AV; Stepacheva TA; D'iakova ML; Shilov SN; Bolotskaia LA
    Klin Med (Mosk); 2005; 83(4):56-9. PubMed ID: 15941146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy of ivabradin and nebivolol addition in combined treatment of ischemic heart disease patients with left ventricular dysfunction].
    Tatarchenko IP; Pozdniakova NV; Biriuchenko MV; Kapelovich VIu; Sekerko SA; Kupaeva RA
    Ter Arkh; 2008; 80(9):40-4. PubMed ID: 19555036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of nebivolol on remodeling of the heart and vessels and the state of hemodynamics in patients with hypertension].
    Gromnatskiĭ NI; Dius'mikeeva NB
    Kardiologiia; 2002; 42(10):27-30. PubMed ID: 12494053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.